SRp55 Regulates a Splicing Network That Controls Human Pancreatic β-Cell Function and Survival
- PMID: 29246973
- PMCID: PMC5828453
- DOI: 10.2337/db17-0736
SRp55 Regulates a Splicing Network That Controls Human Pancreatic β-Cell Function and Survival
Abstract
Progressive failure of insulin-producing β-cells is the central event leading to diabetes, but the signaling networks controlling β-cell fate remain poorly understood. Here we show that SRp55, a splicing factor regulated by the diabetes susceptibility gene GLIS3, has a major role in maintaining the function and survival of human β-cells. RNA sequencing analysis revealed that SRp55 regulates the splicing of genes involved in cell survival and death, insulin secretion, and c-Jun N-terminal kinase (JNK) signaling. In particular, SRp55-mediated splicing changes modulate the function of the proapoptotic proteins BIM and BAX, JNK signaling, and endoplasmic reticulum stress, explaining why SRp55 depletion triggers β-cell apoptosis. Furthermore, SRp55 depletion inhibits β-cell mitochondrial function, explaining the observed decrease in insulin release. These data unveil a novel layer of regulation of human β-cell function and survival, namely alternative splicing modulated by key splicing regulators such as SRp55, that may cross talk with candidate genes for diabetes.
© 2017 by the American Diabetes Association.
Figures
Similar articles
-
The RNA-binding profile of the splicing factor SRSF6 in immortalized human pancreatic β-cells.Life Sci Alliance. 2020 Dec 29;4(3):e202000825. doi: 10.26508/lsa.202000825. Print 2021 Mar. Life Sci Alliance. 2020. PMID: 33376132 Free PMC article.
-
GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim.PLoS Genet. 2013 May;9(5):e1003532. doi: 10.1371/journal.pgen.1003532. Epub 2013 May 30. PLoS Genet. 2013. PMID: 23737756 Free PMC article.
-
Zinc-induced modulation of SRSF6 activity alters Bim splicing to promote generation of the most potent apoptotic isoform BimS.FEBS J. 2013 Jul;280(14):3313-27. doi: 10.1111/febs.12318. Epub 2013 Jun 3. FEBS J. 2013. PMID: 23648111
-
When one becomes many-Alternative splicing in β-cell function and failure.Diabetes Obes Metab. 2018 Sep;20 Suppl 2(Suppl 2):77-87. doi: 10.1111/dom.13388. Diabetes Obes Metab. 2018. PMID: 30230174 Free PMC article. Review.
-
Sweet Killing in Obesity and Diabetes: The Metabolic Role of the BH3-only Protein BIM.J Mol Biol. 2018 Sep 14;430(18 Pt B):3041-3050. doi: 10.1016/j.jmb.2018.07.022. Epub 2018 Jul 21. J Mol Biol. 2018. PMID: 30036494 Review.
Cited by
-
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer.Sci Adv. 2024 Oct 4;10(40):eado8231. doi: 10.1126/sciadv.ado8231. Epub 2024 Oct 2. Sci Adv. 2024. PMID: 39356765 Free PMC article.
-
Two Novel NF1 Pathogenic Variants Causing the Creation of a New Splice Site in Patients With Neurofibromatosis Type I.Front Genet. 2019 Aug 22;10:762. doi: 10.3389/fgene.2019.00762. eCollection 2019. Front Genet. 2019. PMID: 31507634 Free PMC article.
-
The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes.Nat Genet. 2019 Nov;51(11):1588-1595. doi: 10.1038/s41588-019-0524-6. Epub 2019 Nov 1. Nat Genet. 2019. PMID: 31676868 Free PMC article.
-
A functional genomic approach to identify reference genes for human pancreatic beta cell real-time quantitative RT-PCR analysis.Islets. 2021 Jul 4;13(3-4):51-65. doi: 10.1080/19382014.2021.1948282. Epub 2021 Jul 9. Islets. 2021. PMID: 34241569 Free PMC article.
-
Compound heterozygous splicing variants expand the genotypic spectrum of EMC1-related disorders.Clin Genet. 2023 May;103(5):553-559. doi: 10.1111/cge.14311. Epub 2023 Feb 27. Clin Genet. 2023. PMID: 36799557 Free PMC article.
References
-
- Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005;54(Suppl. 2):S97–S107 - PubMed
-
- Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008;10(Suppl. 4):32–42 - PubMed
-
- Dupuis J, Langenberg C, Prokopenko I, et al. .; DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium; Anders Hamsten on behalf of Procardis Consortium; MAGIC investigators . New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105–116 - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
